164 related articles for article (PubMed ID: 21689709)
1. Reduced immune response to influenza A (H1N1) 2009 monovalent vaccine in HIV-infected Japanese subjects.
Yanagisawa N; Maeda K; Ajisawa A; Imamura A; Suganuma A; Ando M; Takayama N; Okuno Y
Vaccine; 2011 Aug; 29(34):5694-8. PubMed ID: 21689709
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity and safety of monovalent influenza A (H1N1) 2009 in HIV-infected Thai children.
Phongsamart W; Sirisanthana V; Wittawatmongkol O; Maleesatharn A; Sudjaritruk T; Chearskul P; Aurpibul L; Sirisanthana T; Chokephaibulkit K
Vaccine; 2011 Nov; 29(47):8705-11. PubMed ID: 21893147
[TBL] [Abstract][Full Text] [Related]
3. Response to 2009 pandemic and seasonal influenza vaccines co-administered to HIV-infected and HIV-uninfected former drug users living in a rehabilitation community in Italy.
Pariani E; Boschini A; Amendola A; Poletti R; Anselmi G; Begnini M; Ranghiero A; Cecconi G; Zanetti AR
Vaccine; 2011 Nov; 29(49):9209-13. PubMed ID: 21974995
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity and safety of inactivated monovalent 2009 H1N1 influenza A vaccine in immunocompromised children and young adults.
Hakim H; Allison KJ; Van De Velde LA; Li Y; Flynn PM; McCullers JA
Vaccine; 2012 Jan; 30(5):879-85. PubMed ID: 22155630
[TBL] [Abstract][Full Text] [Related]
5. Improved serological response to H1N1 monovalent vaccine associated with viral suppression among HIV-1-infected patients during the 2009 influenza (H1N1) pandemic in the Southern Hemisphere.
Maruszak H; Jeganathan S; Smith DE; Robertson P; Barnes T; Furner V
HIV Med; 2012 Jul; 13(6):352-7. PubMed ID: 22296264
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity and tolerability of an inactivated and adjuvanted pandemic H1N1 influenza vaccine, in HIV-1-infected patients.
Tremblay CL; Rouleau D; Fortin C; Toma E; Sylla M; Cyr L; Cote S; Baz M; Sampalis J; Trautman L; Sékaly RP; Boivin G
Vaccine; 2011 Feb; 29(7):1359-63. PubMed ID: 21185423
[TBL] [Abstract][Full Text] [Related]
7. Response to a monovalent 2009 influenza A (H1N1) vaccine.
Greenberg ME; Lai MH; Hartel GF; Wichems CH; Gittleson C; Bennet J; Dawson G; Hu W; Leggio C; Washington D; Basser RL
N Engl J Med; 2009 Dec; 361(25):2405-13. PubMed ID: 19745216
[TBL] [Abstract][Full Text] [Related]
8. Immune response to influenza A (H1N1)v monovalent MF59-adjuvanted vaccine in HIV-infected patients.
Fabbiani M; Di Giambenedetto S; Sali M; Farina S; Sansonetti P; Tamburrini E; Dal Verme LZ; Delogu G; De Luca A; Kelvin D; Cauda R; Fadda G
Vaccine; 2011 Apr; 29(16):2836-9. PubMed ID: 21349364
[TBL] [Abstract][Full Text] [Related]
9. Safety and immunogenicity of a 2009 influenza A (H1N1) vaccine in hemodialysis patients.
Lertdumrongluk P; Changsirikulchai S; Limkunakul C; Prachukthum P; Punpiput P; Buppanharun R; Chotpitayasunondh C
Vaccine; 2012 Feb; 30(6):1108-14. PubMed ID: 22178515
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity and safety of a China-made monovalent pandemic (H1N1) 2009 influenza A vaccine in healthcare workers in Guangzhou, China.
Zhan Y; Yang Z; Li L; Ye D; Wu H; Fu R; Zhao S; Wang Y; Zhou R; Chen R
Jpn J Infect Dis; 2011; 64(3):190-4. PubMed ID: 21617301
[TBL] [Abstract][Full Text] [Related]
11. Immune response to 2009 pandemic H1N1 influenza virus A monovalent vaccine in children with cancer.
Yen TY; Jou ST; Yang YL; Chang HH; Lu MY; Lin DT; Lin KH; Huang LM; Chang LY
Pediatr Blood Cancer; 2011 Dec; 57(7):1154-8. PubMed ID: 21425448
[TBL] [Abstract][Full Text] [Related]
12. A clinical study to assess the immunogenicity and safety of a monovalent 2009 influenza A (H1N1) vaccine in an area with low-level epidemics of pandemic influenza.
Kung HC; Huang KC; Kao TM; Lee YC; Chang FY; Wang NC; Liu YC; Lee WS; Liu HJ; Chen CI; Chen CH; Huang LM; Hsieh SM
Vaccine; 2010 Oct; 28(45):7337-43. PubMed ID: 20817013
[TBL] [Abstract][Full Text] [Related]
13. Antibody responses to trivalent influenza vaccine in Iranian adults infected with human immunodeficiency virus.
Rasoolinejad M; Jafari S; Montazeri M; Mohseni M; Foroughi M; Moradmand Badie B; Saatian M; Marashi SM; Mokhtari Azad T
Acta Med Iran; 2013 Apr; 51(3):148-52. PubMed ID: 23605597
[TBL] [Abstract][Full Text] [Related]
14. Low rate of seroconversion after vaccination with a split virion, adjuvanted pandemic H1N1 influenza vaccine in HIV-1-infected patients.
Bickel M; Wieters I; Khaykin P; Nisius G; Haberl A; Stephan C; Von Hentig N; Herrmann E; Doerr HW; Brodt HR; Allwinn R
AIDS; 2010 Jun; 24(9):F31-5. PubMed ID: 20559034
[TBL] [Abstract][Full Text] [Related]
15. Diminished immunogenicity to pandemic H1N1 2009 influenza vaccine in subjects with severe motor and intellectual disability.
Hara M; Hanaoka T; Mizushima T; Honma J; Maeda K; Ohfuji S; Tanaka K; Hirota Y
Vaccine; 2011 Oct; 29(46):8323-9. PubMed ID: 21893146
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity of a monovalent pandemic influenza A H1N1 vaccine in health-care workers of a university hospital in Japan.
Igari H; Segawa S; Watanabe A; Suzuki A; Watanabe M; Sakurai T; Kuroda F; Watanabe M; Tatsumi K; Nakayama M; Nakayama T; Suzuki K; Sato T
Microbiol Immunol; 2010 Oct; 54(10):618-24. PubMed ID: 21118299
[TBL] [Abstract][Full Text] [Related]
17. Influenza vaccination of human immunodeficiency virus (HIV)-infected adults: impact on plasma levels of HIV type 1 RNA and determinants of antibody response.
Fuller JD; Craven DE; Steger KA; Cox N; Heeren TC; Chernoff D
Clin Infect Dis; 1999 Mar; 28(3):541-7. PubMed ID: 10194075
[TBL] [Abstract][Full Text] [Related]
18. Pandemic influenza A/H1N1 vaccine administered sequentially or simultaneously with seasonal influenza vaccine to HIV-infected children and adolescents.
Esposito S; Tagliaferri L; Daleno C; Valzano A; Picciolli I; Tel F; Prunotto G; Serra D; Galeone C; Plebani A; Principi N
Vaccine; 2011 Feb; 29(8):1677-82. PubMed ID: 21199699
[TBL] [Abstract][Full Text] [Related]
19. Improved neutralizing antibody response in the second season after a single dose of pandemic (H1N1) 2009 influenza vaccine in HIV-1-positive adults.
Kikuchi T; Iwatsuki-Horimoto K; Adachi E; Koga M; Nakamura H; Hosoya N; Kawana-Tachikawa A; Koibuchi T; Miura T; Fujii T; Kawaoka Y; Iwamoto A
Vaccine; 2012 Jun; 30(26):3819-23. PubMed ID: 22504038
[TBL] [Abstract][Full Text] [Related]
20. Short communication: immunogenicity of an inactivated influenza vaccine and postvaccination influenza surveillance in HIV-infected and noninfected children and adolescents.
Machado AA; Machado CM; Boas LS; Lopes MC; Gouvêa Ade F; Succi RC; Mendoza TR; Kanashiro TM; Machado DM
AIDS Res Hum Retroviruses; 2011 Sep; 27(9):999-1003. PubMed ID: 21284525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
